freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Cheap drugs Aricept and Ebixa could delay symptoms of advanced Alzheimer's disease

Published on 08/03/2012

Hundreds of thousands of dementia patients could benefit from staying on certain drugs for longer, say researchers from King’s College London.

Two drugs, known as Aricept and Ebixa, are given to around 50,000 patients in the early and moderate stages of Alzheimer’s. Once the illness has progressed beyond a certain point the prescription is usually stopped, and the drugs are believed to have no further benefit.

The symptoms of Alzheimer's disease could be delayed with the use of cheap drugs

However, a ground-breaking study carried out at King’s College London and published in the New England Journal of Medicine, show that patients who stay on the drugs longer have their symptoms delayed by around four months.

Alzheimer's disease is the most common form of dementia, which is a group of symptoms associated with a decline in mental abilities, such as memory and reasoning. Around 500,000 people in the UK are estimated to have Alzheimer’s, but 60 per cent have not been properly diagnosed and are not given correct drugs and care.

In the study, researchers divided 295 patients with advanced Alzheimer’s disease into four groups. One group was given Aricept, the second group Exbixa, the third group were given both drugs and the fourth group was given a placebo.

After a year, the patients were assessed on their cognitive scores on factors like memory, and how well they coped with everyday tasks like dressing and eating.

The results showed that whilst the drugs were unable to halt the decline of patients they did slow it down. Those on either of the two drugs had much higher scores than the other patients, and researchers estimated that they delayed symptoms by three or four months.

Experts believe that these drugs could replace harmful anti-psychotic medication which is routinely used to sedate patients in the later stages of Alzheimer’s disease.

Now, the researchers hope that their findings will prompt the National Institute for Health and Clinical Excellence to draw up new guidelines recommending the drugs for later stages of the disease. Aricept currently costs 50p per day per patient, and Ebixa £2.80 a day per patient.

Professor Robert Howard, lead author of the study, said: ‘For the first time we have robust and compelling evidence that treatment with these drugs can continue to help patients at the later, more severe stages of the disease.’

Since Alzheimer's disease is a chronic condition, it will not be covered by private medical insurance. However, to get cover for other illnesses compare health insurance quotes online now.

© ActiveQuote Ltd. 2012

Categories:  Medical
Cheap drugs Aricept and Ebixa could delay symptoms of advanced Alzheimer's diseaseHundreds of thousands of dementia patients could benefit from staying on certain drugs for longer, say researchers from King’s College Londo    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member

The advisor was incredibly helpful and fully explained the differences between the policies. I really liked the fact that I was put under no pressure.

Review centre member

I was pleasantly surprised with the in-depth knowledge, the efficiency and the nice and polite manner of the staff - the explanations were made very clearly.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...